Dr. Sherry Wang

Assistant Professor

Pharmacy, School of Pharmacy

Office Location: 9401 206

Phone: 714-516-5487

Email: yunwang@chapman.edu

Scholarly Works:: Google Scholar

Education:: China Pharmaceutical University, Bachelor of Science
University of Hong Kong, Master of Philosophy
The Chinese University of Hong Kong, Ph.D.

Biography

Dr. Yun "Sherry" Wang, Ph.D., is a tenure-track Assistant Professor at Chapman University School of Pharmacy (CUSP), where she leads the Research Center for Healthcare AI Initiative. Her research program adopts an interdisciplinary approach that integrates methodologies from machine learning, epidemiology, clinical pharmacy, health economics, and health services research to improve healthcare delivery and outcomes. With international experience across Asia, Australia, and the United States, Dr. Wang possesses a comprehensive understanding of healthcare system complexities, which informs her development of widely applicable solutions.

Dr. Wang's research leverages real-world data (RWD) and advanced analytical techniques to address critical challenges in healthcare. She focuses on optimizing care pathways, particularly for chronic disease management and addiction, by identifying strategies to enhance healthcare delivery efficiency and effectiveness. Dr. Wang addresses issues related to access to and quality of care, particularly for populations impacted by substance use disorders and those facing challenges in obtaining care.

Her scholarly work has been published in some of the most respected journals in her field, including JAMA, The Lancet, Clinical Infectious Diseases, and Neuroepidemiology. Dr. Wang also serves on the editorial boards of several prominent journals, including Scientific Reports and Health Economics, and has contributed to special issues, such as "Opioid Epidemic during the COVID-19 Pandemic" in Healthcare. Additionally, her research has garnered attention in media outlets such as ISPOR News Across Asia, Physician Weekly, HealthHats Podcast, and Health Design Podcast by the Journal of Health Design.

Dr. Wang’s work has been supported by the National Institutes of Health’s AIM-AHEAD program, the McGovern Foundation's McGovern Training Program in Trusted AI, the Office of Research at Chapman University, the American Association of Colleges of Pharmacy (AACP), and the CRE2 at Washington University in St. Louis. In recognition of her groundbreaking work, Dr. Wang has received several prestigious awards. She was honored with the AACP New Investigator Award in 2022, and in 2025, she was named a finalist for the Women in AI Awards North America in the "AI in Research Award – AI Researcher of the Year" category, a recognition that highlights her significant contributions to the intersection of AI and healthcare. Dr. Wang has also received fellowships and scholarships from organizations such as the China Health Policy and Management Society (CHPAMS) and the Asian Future Leaders Scholarship Program (AFLSP). Her research has been referenced in key policy documents, including a report by the California Legislative Analyst’s Office (LAO) and the Washington State Department of Health COVID-19 Literature Situation Report.

Her dedication to fostering the next generation of researchers is evident through her mentorship, which has resulted in one of her Ph.D. students receiving the James L. Doti Outstanding Graduate Student Award, the highest honor for graduate students at Chapman University. Dr. Wang is a dedicated mentor who is deeply committed to guiding graduate students, visiting scholars, undergraduate students, and high school students in their academic and professional growth.

Recent Creative, Scholarly Work and Publications: Chen, J., Wang, Y., Zeb, A., Suzauddola, M. D., Wen, Y., & Alzheimer’s Disease Neuroimaging Initiative. (2025). Multimodal mixing convolutional neural network and transformer for Alzheimer’s disease recognition. Expert Systems with Applications, 259, 125321.; Adekunle, O. A., Wang, Y. S., Yunusa, I., Fleming, M. L., Seoane-Vazquez, E., & Brown, L. M. (2024). Predisposing, Enabling, and Need Factors Influencing Health-related Quality of Life Among People with Metabolic Syndrome. Journal of the American Pharmacists Association, 102255.; Heshmatipour, M., Ng, D. Q., Truong, E. Y. W., Zheng, J., Chan, A., & Wang, Y. (2024). Impact of COVID-19 Pandemic on Emergency Department Visits for Opioid Use Disorder Across University of California Health Centers. Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health.; Ng, D. Q., Lee, S., Lee, R. T., Wang, Y., & Chan, A. (2024). Real-world impact of acupuncture on analgesics and healthcare resource utilization in breast cancer survivors with pain. BMC medicine, 22(1), 394.; Adekunle, O. A., Schommer, J. C., Wang, Y. S., Yunusa, I., Fleming, M. L., Seoane-Vazquez, E., & Brown, L. M. (2024). Perceptions of metabolic syndrome management utilization in relation to patient experience and health-related quality of life. Exploratory Research in Clinical and Social Pharmacy, 100457.; Adekunle, O., Fleming, M., Schommer, J. C., Wang, Y., Yunusa, I., Seoane-Vazquez, E., & Brown, L. M. (2024). PCR93 Assessment of Prior Experience With Pharmacists and Perceptions of Pharmacists’ Education and Training on Metabolic Syndrome (MetS) Patients’ Willingness to Accept Pharmacist-Provided Services. Value in Health, 27(6), S313.; Adekunle, O., Wang, Y., Yunusa, I., Fleming, M., Seoane-Vazquez, E., & Brown, L. M. (2024). EE280 Price Trends and Analysis of Targeted Immunomodulatory (TIM) Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Therapy. Value in Health, 27(6), S109.; Wang, Y., Snell, J. K., Watson, D., Wen, Y., Varisco, T., & Sambamoorthi, U. (2024). RWD34 Examining Bias in the Narxcare Score: Unveiling Disparities in AI/ML Features for Opioid Prescribing Decisions. Value in Health, 27(6), S363.; Ahadian, Pegah, Wei Xu, Sherry Wang, and Qiang Guan. "Adopting Trustworthy AI for Sleep Disorder Prediction: Deep Time Series Analysis with Temporal Attention Mechanism and Counterfactual Explanations." arXiv preprint arXiv:2412.18971 (2024).; Wang, Yun, Hao Wang, Drake Watson, Kabir Snell Jose, Ryan Stofer, Quinton Ding Quan Ng, Chih-Hung Chang, Karen A. Miotto, Matthew Heshmatipour, and Alexandre Chan. "Change of opioid prescribing before and after the COVID pandemic in California, 2017-2022." (2024).; Wang, Yun, Drake Waston, Hao Wang, Karen A. Miotto, Kabir Snell Jose, Tyler J. Varisco, and Usha Sambamoorthi. "Measurement Bias in Machine Learning-Enhanced Opioid Risk Scoring Systems." (2024).; Wang, Yun, Tao Hu, Moom Roosan, Chih-Hung Chang, Matthew Heshmatipour, Jeff Jianfei Guo, and Karen A. Miotto. "Assessing Buprenorphine Treatment Utilization and SAMHSA DATA Waiver Provider Distribution in 2021: A Real-World Analysis in California." (2024).; Zheng, J., Rakovski, C., Varisco, T., Chen, H., Fleming, M., & Wang, Y. (2023). EPH198 The Sustained Impact of COVID-19 on Opioid Dispensing in California. Value in Health, 26(6), S200.; Wang, Y., Zheng, J., Lam, J., & Gutierrez, M. (2023). EPH251 Neighborhood Characteristics of Availability of Buprenorphine-Prescribing Clinicians and X-Waivered Clinicians. Value in Health, 26(6), S208.; Lu, H., Zheng, J., & Wang, Y. (2023, June). Geospatial Analysis of Opioid Dispensing Patterns in California: A 2021 Real-World Study. In Healthcare (Vol. 11, No. 12, p. 1732). MDPI.; Wang, Y., Zheng, J., Schneberk, T., Ke, Y., Chan, A., Hu, T., ... & Nichol, M. B. (2023). What quantifies good primary care in the United States? A review of algorithms and metrics using real-world data. BMC Primary Care, 24(1), 1-9.; Nedjat, S., Wang, Y., Eshtiaghi, K., & Fleming, M. (2023). Is there a disparity in medications for opioid use disorder based on race/ethnicity and gender? A systematic review and meta-analysis. Research in Social and Administrative Pharmacy.; Wang, Y., Chan, A., Beuttler, R., Fleming, M. L., Schneberk, T., Nichol, M., & Lu, H. (2024, January). Real-world dispensing of buprenorphine in California during prepandemic and pandemic periods. In Healthcare (Vol. 12, No. 2, p. 241). MDPI.; Khan, J., Greaves, E., Tanton, C., Kuper, H., Shakespeare, T., Kpokiri, E., ... & Wu, D. (2023). Sexual behaviours and sexual health among middle-aged and older adults in Britain. Sexually Transmitted Infections, 99(3), 173-179.; Ung, D., Wang, Y., Sundararajan, V., Lopez, D., Kilkenny, M. F., Cadilhac, D. A., ... & Andrew, N. E. (2022). Optimal measures for primary care physician encounters after stroke and association with survival: a data linkage study. Neuroepidemiology, 56(2), 90-96.; Wang, Y., Wu, D., Chan, A., Chang, C. H., Lee, V. W., & Nichol, M. B. (2022). Temporal trend of opioid and nonopioid pain medications: results from a national in-home survey, 2001 to 2018. Pain Reports, 7(3).; Wu, D., Wang, Y., Yang, S. Z., Wang, N., Sun, K. S., Lam, T. P., & Zhou, X. D. (2022). A Socio-ecological Framework for Understanding Workplace Violence in China’s Health Sector: A Qualitative Analysis of Health Workers' Responses to an Open-ended Survey Question. Journal of interpersonal violence, 37(11-12), NP9168-NP9190.; Li, Y., Qin, C., Qiu, S., He, Y., Pang, L., Xu, X., ... & Wu, D. (2023). The effectiveness of pay-it-forward in addressing HPV vaccine delay and increasing uptake among 15–18-year-old adolescent girls compared to user-paid vaccination: a study protocol for a two-arm randomized controlled trial in China. BMC public health, 23(1), 48.; Lu, H., Barrett, A., Pierce, A., Zheng, J., Wang, Y., Chiang, C., & Rakovski, C. (2023). Predicting suicidal and self-injurious events in a correctional setting using AI algorithms on unstructured medical notes and structured data. Journal of psychiatric research, 160, 19-27.; Preciado, S. M., Elsaid, K. A., Fawaz, S., Brown, L., Seoane-Vazquez, E., Fleming, M., & Wang, Y. (2022, August). Exploratory Analysis of Outpatient Visits for US Adults Diagnosed with Lupus Erythematosus: Findings from the National Ambulatory Medical Care Survey 2006–2016. In Healthcare (Vol. 10, No. 9, p. 1664). MDPI.; Lee, V. W., Wang, S. Y., Li, J. T., & Lam, A. S. (2022). Evidence of the Impact of Programmes to Prevent and Manage Heart Disease and Stroke. In Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy (pp. 1-45). Cham: Springer International Publishing.; Cai, J., Wang, Y., Wang, F., Lu, J., Li, L., & Zhou, X. (2021). The association of parent-child communication with internet addiction in left-behind children in china: a cross-sectional study. International Journal of Public Health, 66, 630700.; Wang, Y., Liu, Y., Waldron, M., Houston-Ludlam, A. N., McCutcheon, V. V., Lynskey, M. T., ... & Lian, M. (2021). Temporal trends in smoking and nicotine dependence in relation to co-occurring substance use in the United States, 2005–2016. Drug and Alcohol Dependence, 226, 108903.

Dr. Sherry Wang

Biography

Recent Creative, Scholarly Work and Publications

Faculty Directories by School or College